胰腺囊肿监测中偶发发现的临床意义与MRI方案设计
本研究回顾性分析6174例胰腺囊肿监测患者的腹部MRI和CT报告,使用大语言模型识别偶发发现。43.0%的检查存在偶发发现,其中98.7%为非肿瘤性,70.2%无需进一步处理。经EHR核查确认19例胰腺外肿瘤,在单纯囊肿监测组中仅占0.10%,提示该类患者胰腺外肿瘤负担极低,支持在特定人群中评估缩小视野或无对比剂MRI方案的可行性。
要点
- 单纯胰腺囊肿监测患者胰腺外恶性肿瘤极罕见,发生率仅0.10%
- 伴其他临床指征的监测患者胰腺外肿瘤风险显著升高,需全面阅片
- 偶然发现的胰腺内富血供病灶较少见,多为神经内分泌肿瘤
核心结论
- 胰腺囊肿监测期间临床显著的胰腺外肿瘤罕见,尤其在单纯囊肿监测和高危胰腺筛查患者中
- 低胰腺外肿瘤负担提示缩小视野或无对比剂MRI方案值得在特定人群中进一步评估
- 大语言模型对影像报告中偶发发现的识别与人工审核一致性高,Cohen κ为0.857和0.882
研究设计与样本
- 单中心回顾性研究,分析2005至2025年胰腺囊肿监测的腹部MRI和CT报告
- 共纳入6174例患者,平均年龄70.6±12.3岁,女性占65.7%,94.8%接受MRI检查
- 采用大语言模型识别与临床指征无关的偶发发现,选取每例患者最早的监测检查报告
- 患者分为单纯囊肿监测组、高危胰腺筛查组和伴其他临床指征组,EHR核查可疑胰腺外肿瘤性偶发发现
- 大语言模型性能在100份抽样报告中经两名审核者验证
关键影像表现/征象
- 偶发发现以非肿瘤性为主,占98.7%
- 胰腺外肿瘤中最常见为肾肿瘤,共14例
- 偶然发现的胰腺内富血供病灶共31例,占0.50%,最终诊断包括25例神经内分泌肿瘤和4例胰腺内副脾
诊断标准与关键数值
- 偶发发现在全部检查中占比43.0%,其中70.2%无需进一步处理
- 胰腺外肿瘤在伴其他指征组中占比为1.55%,高于单纯监测组的0.10%
- 伴其他指征组较单纯监测组的胰腺外肿瘤校正比值比为14.20,95%CI为5.09-39.61,p<0.001
- 高危胰腺筛查组446例中未检出胰腺外肿瘤,95%CI为0.00-0.82%
- 大语言模型与审核者一致性Cohen κ分别为0.857和0.882
临床应用与阅片要点
- 单纯囊肿监测患者阅片可重点关注胰腺及胰周区域,胰腺外临床显著病变极罕见
- 伴其他临床指征的囊肿监测患者胰腺外肿瘤风险显著升高,应进行全面阅片
- 胰腺内富血供病灶需鉴别神经内分泌肿瘤与胰腺内副脾
局限性
- 单中心回顾性研究设计存在选择偏倚可能
- 研究未直接评估缩小视野或无对比剂MRI方案的诊断效能
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the prevalence and clinical relevance of incidental findings detected during pancreatic cyst surveillance and explore their implications for pancreas-focused imaging protocols.
METHODS: This single-center retrospective study analyzed abdominal MRI and CT reports for pancreatic cyst surveillance (2005-2025) using a large language model (LLM). Incidental findings were findings unrelated to the clinical indication. Only the earliest surveillance examination per patient was included. Patients were stratified into cyst-only surveillance (cyst-only), cyst surveillance with high-risk pancreatic screening (cyst-HRI), or cyst surveillance with additional clinical indications (cyst-other). Electronic health record (EHR) review evaluated suspected extrapancreatic neoplastic incidental findings and incidental intrapancreatic hyperenhancing lesions. LLM performance was validated against two reviewers in 100 sampled reports. Multivariable logistic regression adjusted for age and sex.
RESULTS: 6174 patients (mean age, 70.6 ± 12.3 years; 65.7% women) were included; 94.8% underwent MRI. LLM-reviewer agreement was high (Cohen κ = 0.857 and 0.882). Incidental findings were identified in 43.0% of examinations and were predominantly nonneoplastic (98.7%), with most not requiring further action (70.2%). EHR targeted review confirmed 19 extrapancreatic neoplasms, most commonly renal neoplasms (n = 14). Extrapancreatic neoplasms were more frequent in cyst-other than cyst-only patients (14/906 [1.55%] vs. 5/4,822 [0.10%]; aOR, 14.20; 95% CI 5.09-39.61; p < 0.001). No extrapancreatic neoplasms were identified in cyst-HRI patients (0/446; 95% CI 0.00-0.82%). Incidentally detected intrapancreatic hyperenhancing lesions were uncommon (31/6,174, 0.50%); final diagnoses included 25 neuroendocrine tumors and four intrapancreatic splenules.
CONCLUSION: Clinically significant extrapancreatic neoplasms were rare during pancreatic cyst surveillance, particularly among cyst-only and cyst-HRI patients. While this study did not directly assess the diagnostic performance of reduced field-of-view or non-contrast MRI, the low burden of extrapancreatic neoplasms suggests these protocol strategies warrant further evaluation in selected populations.
引用
- Liu, Shen, Chandarana, et al. Incidental findings during pancreatic cyst surveillance: clinical relevance and implications for MRI protocol design. Abdom Radiol (NY). 2026. PMID: 42517903. doi:10.1007/s00261-026-05710-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。